WallStreetZenWallStreetZen

NYSEMKT: MAIA
Maia Biotechnology Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their MAIA stock forecasts and price targets.

Forecast return on equity

Is MAIA forecast to generate an efficient return?

Forecast return on assets

Is MAIA forecast to generate an efficient return on assets?

MAIA revenue forecast

What is MAIA's revenue in the next 1 years based on estimates from 1 analyst?
Avg 1 year Forecast
$35.4M

MAIA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
MAIA$1.96N/AN/A
ICCC$5.05N/AN/A
PMN$2.00N/AN/A
UNCY$1.09$5.63+416.06%Strong Buy
CARA$0.69$4.63+570.29%Buy

Maia Biotechnology Stock Forecast FAQ

What is MAIA's revenue growth forecast for 2025-2025?

(NYSEMKT: MAIA) Maia Biotechnology's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 252.28%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.58%.

Maia Biotechnology's revenue in 2024 is $0.

In 2025, MAIA is forecast to generate $707,900,012 in revenue, with the lowest revenue forecast at $707,900,012 and the highest revenue forecast at $707,900,012.

If you're new to stock investing, here's how to buy Maia Biotechnology stock.

What is MAIA's forecast return on assets (ROA) for 2025-2025?

(NYSEMKT: MAIA) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 9.71%.

What is MAIA's forecast return on equity (ROE) for 2025-2025?

(NYSEMKT: MAIA) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.